Tradestie Institutional Equity Comparison Engine

SABA vs HSTM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HSTM Overall Edge

HSTM Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HealthStream Inc (HSTM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SABA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HSTM at 28.6x Forward P/E and 7.8% operating margin (+8.9% YoY). In options structure, SABA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HSTM sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HSTM
SABA N/M vs HSTM 28.6x Fwd P/E
Growth & Margin Winner HSTM
Op Margin N/A vs 7.8% ยท YoY N/A vs +8.9%
Momentum & Technical Winner HSTM
1Y -16.0% vs +6.8% ยท 52W Pos 4% vs 42%
Options & Structure Winner HSTM
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (50th %ile IV)
SABA NYSE
Saba Capital Income & Opportunities Fund II
Institutional Equity
$7.33
-0.27% 1D
Market Cap $251.8M
1M Return -3.68%
1Y Return -16.04%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 38.0 Fund 55.0 Flow 50.0 Mom 55.0
HSTM NASDAQ
HealthStream Inc
Services-Computer Programming, Data Processing, Etc.
$26.29
+0.19% 1D
Market Cap $802.8M
1M Return -24.0%
1Y Return +6.78%
Forward P/E 28.6x
Unified AI Score
50.5 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SABA -16.04% HSTM +6.78% Spread: +22.82 pp (HSTM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SABA TTM Op. Margin: N/A HSTM TTM Op. Margin: 7.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SABA vs HSTM. Trailing 12-month operating profitability (SABA N/A vs HSTM 7.8%) and valuation multiples (SABA N/M vs HSTM 28.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SABA (1) vs HSTM (9)
Institutional Metric SABA HSTM Criterion Row Winner
Market Capitalization Scale $251.8M $802.8M Larger Scale HSTM
Trailing P/E Ratio Valuation N/M 37.5x Lower Multiple HSTM
Forward P/E Ratio Valuation N/M 28.6x Lower Multiple HSTM
Revenue Growth (YoY) Growth N/A +8.9% Higher Growth HSTM
Operating Margin (TTM) Profitability N/A 7.8% Higher Margin HSTM
Net Profit Margin Profitability N/A 6.2% Higher Margin HSTM
Return on Equity (ROE) Capital Efficiency N/A 5.5% Higher ROE HSTM
52-Week Range Position Momentum 4% ($7โ€“$9) 42% ($20โ€“$36) Stronger Trend HSTM
Beta / 30D Volatility Risk Regime 0.37ฮฒ ยท 13% Vol 0.38ฮฒ ยท 44% Vol Lower Realized Risk SABA
Unified Institutional Score Composite Signal 44.2 / 100 (HOLD) 50.5 / 100 (HOLD) Higher Composite HSTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SABA vs HSTM Buy Guide
SABA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SABA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HSTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live HSTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SABA nor HSTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.